ArticleJournal of clinical microbiology2010
Identification of Paecilomyces variotii in clinical samples and settings.
Article in Journal of clinical microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
52 citing papers in PubMed.
- SystemicMedical mycology case reports · 2026Article
- Clinical characteristics, treatment, and outcomes of fungal keratitis/endophthalmitis caused byFrontiers in cellular and infection microbiology · 2026Article
- Identity and diversity of culturable endophytic fungi associated with Capparis spinosa L. in Iran.Scientific reports · 2025Article
- Morpho-molecular characterization and mycotoxin potential of fungi isolated from black and white peppers.Scientific reports · 2025Article
- What are the 100 most cited fungal genera?Studies in mycology · 2024Article
- Severe pneumonia with pleural effusion caused by co-infection of Paecilomyces variotii and Penicillium oxalicum in a diabetic patient.BMC infectious diseases · 2024Article
- Characterization of the complete mitochondrial genome of Paecilomyces variotii and comparative evolutionary mitochondriomics of 36 fungi.Molecular biology reports · 2024Article
- Hand contamination and hand hygiene knowledge and practices among commercial transport users after the SARS-CoV-2 virus (COVID-19) scare, Enugu State, Nigeria.PLOS global public health · 2024Article
- Changes in fungal taxonomy: mycological rationale and clinical implications.Clinical microbiology reviews · 2023Review
- Successful Treatment ofOpen forum infectious diseases · 2023Article
- A Polyphasic Approach including Whole Genome Sequencing RevealsJournal of fungi (Basel, Switzerland) · 2023Article
- Paecilomyces variotti in deep dental caries.Journal of clinical and experimental dentistry · 2022Article
- Draft Genome Sequences of Fungi Isolated from Mars 2020 Spacecraft Assembly Facilities.Microbiology resource announcements · 2022Article
- Article
- Article
- Transcontinental Dispersal of Nonendemic Fungal Pathogens through Wooden Handicraft Imports.mBio · 2022Article
- Species Identification and In Vitro Antifungal Susceptibility ofJournal of fungi (Basel, Switzerland) · 2022Article
- The emerging pathogen Paecilomyces variotii - a novel and important fungal allergen source.Allergy · 2022Article
- Case Report: Novel DisseminatedFrontiers in veterinary science · 2022Article
- Disseminated Rasamsonia argillacea species complex infections in 8 dogs.Journal of veterinary internal medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paecilomyces variotii is a commonly occurring species in air and food, but it is also associated with many types of human infections and is among the emerging causative agents of opportunistic mycoses in immunocompromised hosts. Paecilomyces can cause hyalohyphomycosis, and two species, Paecilomyces lilacinus and P. variotii, are the most frequently encountered organisms. In the present study, a set of 34 clinical isolates morphologically identified as P. variotii or P. lilacinus were formally identified by sequencing intergenic transcribed spacer regions 1 and 2 (including 5.8S rDNA) and a part of the beta-tubulin gene. Three isolates were identified as P. lilacinus, and five of the presumptive P. variotii isolates did not belong to the genus Paecilomyces but were identified as Talaromyces eburneus (anamorph, Geosmithia argillacea) or Hamigera avellanea (anamorph, Merimbla ingelheimense). Applying the most recent taxonomy, we found that the clinical P. variotii isolates could be identified as P. variotii sensu stricto (14 strains), P. formosus (11 strains), and P. dactylethromorphus (1 strain). These data indicate that P. formosus occurs in clinical samples as commonly as P. variotii. Susceptibility tests showed that the antifungal susceptibility profiles of P. variotii, P. formosus, and P. dactylethromorphus are similar and that all strains tested were susceptible to amphotericin B in vitro. P. lilanicus, T. eburneus, and H. avellanea had different susceptibility profiles; and flucytosine and voriconazole were the least active of the antifungal drugs tested against these species. Our results indicate that correct species identification is important to help guide appropriate antifungal therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.